- rx_11
- Senior | Next Rank: 100 Posts
- Posts: 87
- Joined: Mon May 17, 2010 12:31 am
- Thanked: 7 times
- GMAT Score:690
The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the
challenge made above?
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on
patent protection.
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be
marketed, often now take as long as 10 years to complete.
(C) There are several industries in which the ratio of research and development costs to revenues is higher
than it is in the pharmaceutical industry.
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market
alternative drugs, provided they are sufficiently dissimilar to the patented drug.
(E) Much recent industrial innovation has occurred in products-for example, in the computer and electronics
industries-for which patent protection is often very ineffective
OA is B
Hi, everyone
I got completely stucked with this question. Hope anyone can help me.
I can't understand why this one is correct answer. The OE says this choice tells us why pharmaceutical industry is different from other industries. However, I can't understand this because B just tells us it takes 10 years to test a new drug, but we don't know anything about products of other industries. What if a computer takes 15 years to test? So I can't find why the pharmaceutical industry is different from other industries and why the patents should be extended.
Anyone can help me?
Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the
challenge made above?
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on
patent protection.
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be
marketed, often now take as long as 10 years to complete.
(C) There are several industries in which the ratio of research and development costs to revenues is higher
than it is in the pharmaceutical industry.
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market
alternative drugs, provided they are sufficiently dissimilar to the patented drug.
(E) Much recent industrial innovation has occurred in products-for example, in the computer and electronics
industries-for which patent protection is often very ineffective
OA is B
Hi, everyone
I got completely stucked with this question. Hope anyone can help me.
I can't understand why this one is correct answer. The OE says this choice tells us why pharmaceutical industry is different from other industries. However, I can't understand this because B just tells us it takes 10 years to test a new drug, but we don't know anything about products of other industries. What if a computer takes 15 years to test? So I can't find why the pharmaceutical industry is different from other industries and why the patents should be extended.
Anyone can help me?












